Skip to search.
 TSX Up 0.45% TSX Ventures Down 0.04%

Merck & Co. Inc. (MRK)

-NYSE
57.41 Up 0.42(0.74%) 1:48PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:56.99
Open:56.51
Bid:57.37 x 400
Ask:57.38 x 700
1y Target Est:65.47
Beta:0.39
Next Earnings Date:28-Jul-15MRK Earnings announcement
Day's Range:55.83 - 57.53
52wk Range:52.49 - 63.62
Volume:8,655,120
Avg Vol (3m):9,886,100
Market Cap:162.20B
P/E (ttm):14.92
EPS (ttm):3.85
Div & Yield:1.80 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MRKUp 0.74%162.20B
GSKUp 0.10%100.56B
NVSUp 1.08%247.89B
PFEUp 2.53%216.81B

Key Statistics

Forward P/E (1 yr):15.06
P/S (ttm):3.89
Ex-Dividend Date:11-Sep-15

Analysts

Annual EPS Est (Dec-15) :3.45
Quarterly EPS Est (Jun-15) :0.81
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):2.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback